Halozyme's strategic acquisition of Evotec and innovative ENHANZE technology present growth opportunities. Click here for a ...

智通财经APP获悉，据外媒报道， 奥洛兹美医疗 (HALO.US)首席执行官海伦·托利 (Helen Torley)称，公司计划以现金形式融资20亿欧元 (合21亿美元)收购德国Evotec公司 ...

比特币从大选以来最大跌幅中反弹。 比特币价格波动加剧，从美国大选结果出炉以来最大的两天跌幅中反弹，反映出对当选总统特朗普政策议程影响的评估发生了变化。数据显示，比特币在上周六和上周日下跌了近3%。而截至发稿，比特币已涨至仅略低于9.2万美元的水平，但仍低于上周创下的约9.3万美元的历史新高。

据报道，奥洛兹美医疗（HALO.US）首席执行官海伦·托利（Helen Torley）称，公司计划以现金形式融资20亿欧元（合21亿美元）收购德国Evotec公司（EVO.US）。Torley在接受采访时表示：“我们有信心以全额现金交易的方式为这笔交易提供资金。不会动用股权。她表示：“由于我们承担了一些债务，我们强劲的现金流将能够在交易完成后迅速将我们的杠杆率降至两倍。” ...

Halozyme Therapeutics Inc. plans to finance its €2 billion ($2.1 billion) proposed takeover of Germany’s Evotec SE in cash, ...

Halozyme Therapeutics (NYSE:HAL) intends to finance its 2B euro ($2.1B) proposed acquisition of Germany’s Evotec (EVO) in ...

On Thursday, Halozyme Therapeutics, Inc. (NASDAQ:HALO) submitted a non-binding proposal to Evotec SE (NASDAQ:EVO) to acquire ...

Evotec, a drug discoverer facing challenges under CEO Christian Wojczewski, confirmed receiving the unsolicited offer. The ...

Halozyme Therapeutics (HALO) offered to acquire German drug maker Evotec (EVO) in a deal with an equity value of 2 billion euros ($2.11 billion). Halozyme submitted a non-binding proposal to Evotec's ...

Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team SAN ...

Evotec surged on Friday after Halozyme Therapeutics confirmed it had submitted a non-binding proposal to buy the German ...

Evotec SE has attracted takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc. for a deal that would ...